Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 13, 2009

View Archived Issues

Results of first study of avian influenza vaccine in children

Chiome and Chugai sign joint research agreement for monoclonal antibodies

BioSeek and UCB establish new compound evaluation collaboration

Liquidia and Abbott sign collaboration and license agreement for siRNA therapeutics

GSK divulges a series of ghrelin receptor ligands for the treatment of binge eating

New GHS-R1a ligands claimed by GSK as a treatment option for obesity

New TLR modulators disclosed by Technische Universitaet Muenchen

GSK successfully completes tender offer for shares of Genelabs

CTI receives USD 7.5 million from Spectrum under U.S. joint venture agreement for Zevalin

OncoMed imparts novel anti-Jagged 1 monoclonal antibodies with anticancer properties

Novel mGluR2 metabotropic glutamate receptor agonists disclosed by AstraZeneca

Studies show GRII receptor antagonists prevent olanzapine-induced weight gain

First phase III Contrave trial meets co-primary and key secondary endpoints

Poniard presents 2009 clinical goals for development of chemotherapy drug picoplatin

FDA advisory committee recommends approval of Ovation's Sabril for IS and CPS

FDA approves Collegium's nasal inhaled steroid AllerNaze for SAR and PAR

Johnson & Johnson initiates phase I study of risperidone for schizophrenia

FDA issues second complete response letter regarding Merck & Co.'s sBLA for Gardasil

FDA approves Anesiva's sNDA to expand the indication for Zingo to include adults

Altus reports results from completed phase Ic study of ALTU-238

Galapagos and Merck & Co. enter global strategic alliance in obesity and diabetes

ThromboGenics initiates phase III MIVI-TRUST clinical program for microplasmin

Triiodothyronine promotes remyelination in a mouse model of multiple sclerosis

CDDO-imidazolide reduces lung damage in model of chronic obstructive pulmonary disease

Studies compare beta-blockers in adults and elderly patients with heart failure

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...